Literature DB >> 17058223

Controversies in the management of pediatric liver disease: Hepatitis B, C and NAFLD: Summary of a single topic conference.

Benjamin L Shneider1, Regino González-Peralta, Eve A Roberts.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17058223     DOI： 10.1002/hep.21373

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  17 in total

1.  Non-alcoholic fatty liver disease: is iron relevant?

Authors:  Julia O'Brien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2011-08-12       Impact factor: 6.047

Review 2.  Fatty liver in childhood.

Authors:  Yesim Ozturk; Ozlem Bekem Soylu
Journal:  World J Hepatol       Date:  2014-01-27

3.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

4.  Influence of elevated liver fat on circulating adipocytokines and insulin resistance in obese Hispanic adolescents.

Authors:  J S Kim; K-A Lê; S Mahurkar; J N Davis; M I Goran
Journal:  Pediatr Obes       Date:  2012-02-09       Impact factor: 4.000

5.  Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes.

Authors:  Lauren N Bell; Jean P Molleston; Michael J Morton; Ann Klipsch; Romil Saxena; Raj Vuppalanchi; Naga Chalasani
Journal:  J Clin Gastroenterol       Date:  2011-10       Impact factor: 3.062

6.  Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis.

Authors:  Katherine E McGoogan; P Brian Smith; Steve S Choi; Wallace Berman; Ravi Jhaveri
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-03       Impact factor: 2.839

Review 7.  Animal models for the study of liver fibrosis: new insights from knockout mouse models.

Authors:  Hiromitsu Hayashi; Takao Sakai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

Review 8.  Lack of exercise is a major cause of chronic diseases.

Authors:  Frank W Booth; Christian K Roberts; Matthew J Laye
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

Review 9.  Advances in pediatric nonalcoholic fatty liver disease.

Authors:  Rohit Loomba; Claude B Sirlin; Jeffrey B Schwimmer; Joel E Lavine
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

10.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.